# Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation

> **NCT03544762** · PHASE3 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** 18F-FES PET

## Key facts

- **NCT ID:** NCT03544762
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-08
- **Primary completion:** 2020-12
- **Final completion:** 2020-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2019-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03544762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03544762, "Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03544762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*